{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:58:25Z","timestamp":1781344705625,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.vaccine.2008.03.087","type":"journal-article","created":{"date-parts":[[2008,4,19]],"date-time":"2008-04-19T13:20:48Z","timestamp":1208611248000},"page":"3277-3281","source":"Crossref","is-referenced-by-count":129,"title":["Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway"],"prefix":"10.1016","volume":"26","author":[{"given":"Didrik F.","family":"Vestrheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8istein","family":"L\u00f8voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg S.","family":"Aaberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Arne","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Bakke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne R.","family":"Bergsaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.03.087_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.03.087_bib2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.03.087_bib3","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.03.087_bib4","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2008.03.087_bib5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib6","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.33.10.2759-2762.1995","article-title":"Six newly recognized types of Streptococcus pneumoniae","volume":"33","author":"Henrichsen","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.03.087_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/JCM.02199-06","article-title":"Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae","volume":"45","author":"Park","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.03.087_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/341896","article-title":"Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines","volume":"35","author":"Feikin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0950268803001511","article-title":"Systemic pneumococcal disease in Norway 1995\u20132001: capsular serotypes and antimicrobial resistance","volume":"132","author":"Pedersen","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.03.087_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/323339","article-title":"Dynamics of penicillin-susceptible clones in invasive pneumococcal disease","volume":"184","author":"Henriques","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/mdr.2006.9994","article-title":"Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides","volume":"13","author":"Sogstad","year":"2007","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2008.03.087_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.03.087_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"Kayhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.03.087_bib15","first-page":"060202","article-title":"Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme","volume":"11","author":"Bergsaker","year":"2006","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2008.03.087_bib16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment","volume":"365","author":"Stephens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.03.087_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib18","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2007.04.088","article-title":"Herd immunity and pneumococcal conjugate vaccine: a quantitative model","volume":"25","author":"Haber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.03.087_bib19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(00)02779-3","article-title":"Prevention of pneumococcal disease by vaccination: does serotype replacement matter?","volume":"356","author":"Spratt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.03.087_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.03.087_bib21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.03.087_bib22","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization \u2013 WHO position paper","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2008.03.087_bib23","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1016\/j.vaccine.2006.04.042","article-title":"Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program","volume":"24","author":"Wisloff","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08004210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08004210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T15:08:57Z","timestamp":1588604937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08004210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":23,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0264410X08004210"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}